Search
Galantamine
go.drugbank.com/drugs/DB00674ApprovedInvestigational, cognitive impairment in schizophrenia and bipolar disorder, and autism; however, re-development of the drug for Alzheimer’s disease did not commence until the early 1990s due to difficulties in extraction … Galantamine is a tertiary alkaloid and reversible, competitive inhibitor of the acetylcholinesterase (AChE) enzyme, which is a widely studied therapeutic target used in the treatment of Alzheimer's disease
Products: REMINYL ®ER CAPSULAS DE 8 MG, REMINYL ® ER CAPSULAS DE 16 MGSaxagliptin
go.drugbank.com/drugs/DB06335ApprovedInvestigationalSaxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
Categories: Drugs Used in Diabetes, DPP-IV InhibitorsSynonyms: (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrilealpha-Tocopherol succinate
go.drugbank.com/drugs/DB14001ApprovedNutraceuticalVet approvedMoreover, although it is generally believed that alpha-tocopherol succinate would naturally demonstrate such general vitamin E-tocopherol pharmacodynamics after undergoing a logical de-esterification in … In particular, the RRR-alpha-tocopherol (or sometimes called the d-alpha-tocopherol stereoisomer) stereoisomer is considered the natural formation of alpha-tocopherol and generally exhibits the greatest
Mixtures: Ni-C-E-LE Plus, Dialyvite Supreme DCategories: Compounds used in a research, industrial, or household settingIncrease in Intracranial Pressure (ICP)
go.drugbank.com/conditions/DBCOND0113421Synonyms: Increase in Intracranial Pressure (ICP)Leydig Cell Failure in Adult
go.drugbank.com/conditions/DBCOND0081825Drugs: MesteroloneSynonyms: Leydig Cell Failure in Adult, Leydig cell failure in adult (disorder)Burning sensation in the mouth
go.drugbank.com/conditions/DBCOND0102063Drugs: Benzoic acidSynonyms: Discomfort in mouth, Burning sensation in the mouthUrokinase
go.drugbank.com/drugs/DB00013ApprovedInvestigationalWithdrawnUrokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase. … [A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]
Products: UROKINASE-GREEN CROSS INJ. 60,000 iu/vial, UROKINASE KGCC INJ. 250000 IU FLAKON, 1 ADETDeficiencies in enzymes of the urea cycle
go.drugbank.com/conditions/DBCOND0023710Drugs: Phenylbutyric acidSynonyms: Deficiencies in enzymes of the urea cycleRepaglinide
go.drugbank.com/drugs/DB00912ApprovedInvestigationalRepaglinide is extensively metabolized in the liver and excreted in bile. Repaglinide metabolites do not possess appreciable hypoglycemic activity. … Approximately 90% of a single orally administered dose is eliminated in feces and 8% in urine.
Categories: Drugs Used in DiabetesProducts: REPAGLINIDE DOC GENERICI, REPAGLINIDE MYLAN GENERICSKetamine
go.drugbank.com/drugs/DB01221ApprovedInvestigationalVet approvedIt started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic effects. … Ketamine is an NMDA receptor antagonist with a potent anesthetic effect.[A31869] It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories.
Categories: N-Methylaspartate, agonists, N-Methylaspartate, antagonists & inhibitorsSynonyms: DL-ketamine